financetom
Business
financetom
/
Business
/
Cassava Sciences Licenses Simufilam Patent From Yale University for Potential Treatment of Seizures; Shares Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cassava Sciences Licenses Simufilam Patent From Yale University for Potential Treatment of Seizures; Shares Rise
Feb 27, 2025 8:35 AM

11:14 AM EST, 02/27/2025 (MT Newswires) -- Cassava Sciences ( SAVA ) said Thursday it has entered into a license agreement with Yale University for intellectual property rights, including an exclusive US method of treatment patent covering simufilam as a potential treatment for seizures linked to rare neurodevelopmental disorders such as tuberous sclerosis complex.

The licensed patent is based on research and development carried out by a neurosurgery professor at Yale, which showed that Cassava's drug candidate, simufilam, reduced TSC-related seizure frequency in animal models.

Shares of Cassava Sciences ( SAVA ) were up more than 12% in recent Thursday trading.

Price: 2.58, Change: +0.28, Percent Change: +12.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newell Brands Q2 Normalized Earnings, Sales Fall; Full-Year EPS Outlook Cut -- Shares Down Pre-Bell
Newell Brands Q2 Normalized Earnings, Sales Fall; Full-Year EPS Outlook Cut -- Shares Down Pre-Bell
Aug 1, 2025
06:32 AM EDT, 08/01/2025 (MT Newswires) -- Newell Brands ( NWL ) reported Q2 normalized earnings Friday of $0.24 per diluted share, down from $0.35 a year earlier. Analysts polled by FactSet expected $0.24. Net sales for the quarter ended June 30 were $1.94 billion, compared with $2.03 billion a year earlier. Analysts surveyed by FactSet expected $1.95 billion. For...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Kleenex tissue maker Kimberly-Clark's quarterly sales jump on strong demand
Kleenex tissue maker Kimberly-Clark's quarterly sales jump on strong demand
Aug 1, 2025
Aug 1 (Reuters) - Kimberly-Clark ( KMB ) on Friday posted a rise in second-quarter organic sales, led by steady demand for products such as Huggies diapers and Kleenex tissues in domestic and international markets. The Dallas-based firm has broadened its portfolio to offer products from budget to premium price tiers, in an effort to capture demand across income levels...
Avantor Q2 Adjusted Earnings, Sales Fall; Shares Down
Avantor Q2 Adjusted Earnings, Sales Fall; Shares Down
Aug 1, 2025
06:30 AM EDT, 08/01/2025 (MT Newswires) -- Avantor ( AVTR ) reported Q2 adjusted earnings Friday of $0.24 per diluted share, down from $0.25 a year earlier. Analysts polled by FactSet expected $0.25. Net sales for the quarter ended June 3 were $1.68 billion, compared with $1.70 billion a year earlier. Analysts surveyed by FactSet expected $1.67 billion. Shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved